Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc (JAZZ) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · JAZZ · as of Mar 31, 2025
Ownership Breakdown
568
Institutional Holders
▲ 52 vs Q4
$7.45B
Total Inst. Value
▲ $179.62M vs Q4
62.74M
Shares Outstanding
freeFloat 96.91%
60.01M
13F Shares Held
▲ 905,059 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
JAZZ largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 6.02M | 9.87% | 9.87% | $747.06B | May 9, 2025 | ▼ 18.8K |
BLACKROCK, INC. pharmaceutical preparations | 5.77M | 9.45% | 9.45% | $715.77B | May 2, 2025 | ▼ 85.9K |
LSV ASSET MANAGEMENT pharmaceutical preparations | 2.47M | 4.04% | 4.04% | $306.18B | May 9, 2025 | ▼ 64.9K |
DIMENSIONAL FUND ADVISORS LP pharmaceutical preparations | 2.33M | 3.82% | 3.82% | $289.07B | May 13, 2025 | ▲ 293.4K |
STATE STREET CORP pharmaceutical preparations | 1.97M | 3.23% | 3.23% | $244.15B | May 15, 2025 | ▼ 2.2K |
CAPITAL WORLD INVESTORS pharmaceutical preparations | 1.93M | 3.16% | 3.16% | $239.34B | May 12, 2025 | ▲ 4.5K |
ECOR1 CAPITAL, LLC pharmaceutical preparations | 1.71M | 2.80% | 2.80% | $211.86B | May 15, 2025 | — held |
AMERIPRISE FINANCIAL INC pharmaceutical preparations | 1.68M | 2.75% | 2.75% | $208.03B | May 14, 2025 | ▼ 151.9K |
JPMORGAN CHASE & CO pharmaceutical preparations | 1.66M | 2.73% | 2.73% | $206.34B | May 12, 2025 | ▲ 74.5K |
FULLER & THALER ASSET MANAGEMENT, INC. pharmaceutical preparations | 1.33M | 2.18% | 2.18% | $165.24B | May 13, 2025 | ▲ 391.7K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
35
Increased
+4.00M shares2
New Positions
first time holders12
Decreased
−2.15M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.85M
+4.00M / −2.15M
Net new holders
+25
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
JAZZ insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
12
Sell transactions
0.25
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
GALA RENEE D President & CEO | Jun 3, 2026 | Gift | 600 | — | — | 152.2K | Form 4 ↗ |
Patil Neena M EVP & Chief Legal Officer | May 28, 2026 | Sale | 1,192 | $236.97 | $282.5K | 52.6K | Form 4 ↗ |
Pearce Samantha EVP, Chief Commercial Officer | May 28, 2026 | Sale | 6,907 | $235.41 | $1.63M | 50.3K | Form 4 ↗ |
Winningham Rick E director | May 22, 2026 | Sale | 2,741 | $241.57 | $662.1K | 9.6K | Form 4 ↗ |
McSharry Heather Ann director | May 22, 2026 | Sale | 2,000 | $241.00 | $482.0K | 18.4K | Form 4 ↗ |
COZADD BRUCE C director | May 1, 2026 | Sale | 6,000 | $203.33 | $1.22M | 378.7K | Form 4 ↗ |
COZADD BRUCE C director | Apr 1, 2026 | Sale | 3,684 | $190.22 | $700.8K | 387.0K | Form 4 ↗ |
COZADD BRUCE C director | Apr 1, 2026 | Sale | 2,292 | $190.94 | $437.6K | 384.7K | Form 4 ↗ |
COZADD BRUCE C director | Apr 1, 2026 | Sale | 24 | $191.74 | $4.6K | 384.7K | Form 4 ↗ |
COZADD BRUCE C director | Mar 5, 2026 | Tax Withhold | 15,114 | $188.69 | $2.85M | 390.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Jazz Pharmaceuticals plc (JAZZ) is primarily owned by institutional investors, who hold approximately 95.7% of total shares outstanding. Company insiders own approximately 3.09%, while retail and public investors account for the remaining 1.26%.
The largest institutional shareholder of Jazz Pharmaceuticals plc is VANGUARD GROUP INC, holding approximately 6.02 million shares — equal to 9.87% of outstanding shares — as of March 31, 2025.
A total of 568 institutional investors currently hold JAZZ stock, with a combined institutional value of approximately $7.45 billion as of the most recent 13F filing period.
Frequently asked questions
JAZZ ownershipJazz Pharmaceuticals plc (JAZZ) is primarily owned by institutional investors, who hold approximately 95.7% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.87% stake. Company insiders hold 3.09%. Data sourced from SEC Form 13F as of March 31, 2025.